Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-13

FDA Approved: TAVABOROLE — Original Application (Encube Ethicals, Inc.)

View source ↗

Summary

ANDA Original Application approved for Tavaborole topical solution 5% by Encube Ethicals, Inc., a generic version of tavaborole for onychomycosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAVABOROLE TOPICAL SOLUTION, 5% (tavaborole)

Snippet

ORIG AP for TAVABOROLE (TAVABOROLE TOPICAL SOLUTION, 5%)